Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data-Reference-Cited by-同舟云学术

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data

Published:2018-06-20 Issue:6 Volume:13 Page:e0199223
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pane Marika,Coratti Giorgia,Brogna Claudia,Mazzone Elena Stacy,Mayhew Anna,Fanelli Lavinia,Messina Sonia,D’Amico Adele,Catteruccia Michela,Scutifero Marianna,Frosini Silvia,Lanzillotta Valentina,Colia Giulia,Cavallaro Filippo,Rolle Enrica,De Sanctis Roberto,Forcina Nicola,Petillo Roberta,Barp Andrea,Gardani Alice,Pini Antonella,Monaco Giulia,D’Angelo Maria Grazia,Zanin Riccardo,Vita Gian Luca,Bruno Claudio,Mongini Tiziana,Ricci Federica,Pegoraro Elena,Bello Luca,Berardinelli Angela,Battini Roberta,Sansone Valeria,Albamonte Emilio,Baranello Giovanni,Bertini Enrico,Politano Luisa,Sormani Maria Pia,Mercuri Eugenio^ORCID

Funder

Fondazione Telethon

Bioimage Neuromuscular disorders (Eu Grant FP7)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference6 articles.

1. International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy: Rome, 15–16 February 2012;E Mercuri;Neuromuscul Disord,2012

2. A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy;ES Mazzone;Dev Med Child Neurol,2012

3. Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy;A Mayhew;Dev Med Child Neurol,2013

4. Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy;M Pane;Neuromuscul Disord,2014

5. The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys;M Pane;PLoS Curr,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy;2024-08-07

2. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

3. A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice;PLOS ONE;2024-01-25

4. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study;Neuromuscular Disorders;2024-01

5. Design requirements of upper extremity supports for daily use in Duchenne muscular dystrophy with severe muscle weakness;Journal of Rehabilitation and Assistive Technologies Engineering;2024-01